Patent Classification

Drug Delivery System, Aerosol

1. Methods of administering liquid droplet aerosols of nanoparticulate drugs
    
2. Pulmonary delivery for levodopa
    
3. Process for the production of a radioactive aerosol
    
4. Rapid-heating drug delivery article and method of use
    
5. Insulin highly respirable microparticles
    
6. Delivery of antipsychotics through an inhalation route
    
7. High storage stability inhalable compositions
    
8. Reduced aerosol generating formulations
    
9. Highly efficient delivery of a large therapeutic mass aerosol
    
10. Methods and compositions for pulmonary delivery of insulin
     
11. Pharmaceutical aerosol formulation
     
12. Delivery of muscle relaxants through an inhalation route
     
13. Delivery of compounds for the treatment of headache through an inhalation route
     
14. Delivery of caffeine through an inhalation route
     
15. Delivery of antidepressants through an inhalation route
     
16. Delivery of opioids through an inhalation route
     
17. Delivery of compounds for the treatment of Parkinson's through an inhalation route
     
18. Stabilized aerosol dispersions
     
19. Pulmonary delivery of active fragments of parathyroid hormone
     
20. Delivery of sedative-hypnotics through an inhalation route
     
21. Delivery of stimulants through an inhalation route
     
22. Porous particles comprising excipients for deep lung delivery
     
23. Drug administration method
     
24. Aerosol formulations and aerosol delivery of scopolamine
     
25. Aerosol delivery systems
     
26. Powder particles with smooth surface for use in inhalation therapy
     
27. Dispersion for pulmonary delivery of a bioactive agent
     
28. Carbon dioxide enhancement of inhalation therapy
     
29. Small particle liposome aerosols for delivery of anticancer drugs
     
30. Small particle liposome aerosols for delivery of anti-cancer drugs
     
31. HFA suspension formulations containing an anticholinergic
     
32. Aerosol drug inhibition of lung metastases
     
33. Inhalation particles incorporating a combination of two or more active ingredients
     
34. Methods of delivering aerosolized polynucleotides to the respiratory tract
     
35. Dry powder for inhalation
     
36. Particulate compositions for pulmonary delivery
     
37. Controlled release insufflation carrier for medicaments
     
38. Storage stable powder compositions of interleukin-4 receptor
     
39. Delivery of opioids through an inhalation route
     
40. Suspension aerosol formulations of pharmaceutical products
     
41. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
     
42. Pulmonary administration of dry powder formulations for treating infertility
     
43. Delivery of muscle relaxants through an inhalation route
     
44. Suspension aerosol formulations
     
45. Delivery of antihistamines through an inhalation route
     
46. Water stabilized medicinal aerosol formulation
     
47. Particles for inhalation having sustained release properties
     
48. Aerosol delivery systems
     
49. Delivery of beta-blockers through an inhalation route
     
50. Delivery of compounds for the treatment of migraine through an inhalation route
     
51. Milling process for the production of finely milled medicinal substances
     
52. Carrier particles for use in dry powder inhalers
     
53. Delivery of compounds for the treatment of migraine through an inhalation route
     
54. Delivery of stimulants through an inhalation route
     
55. Pulmonary delivery in treating disorders of the central nervous system
     
56. Aerodynamically light particles for pulmonary drug delivery
     
57. Process for preparing powder formulations
     
58. Human medical treatment by aerosol inhalation of immunoglobulin A
     
59. Formulations of steroid solutions for inhalatory administration
     
60. Stable spray-dried protein formulations
     
61. Aerodynamically light particles for pulmonary drug delivery
     
62. Human medical treatment by aerosol inhalation of immunoglobulin A
     
63. Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides
     
64. Formulation for inhalation
     
65. Composition for pulmonary administration comprising a drug and a hydrophobic amino acid
     
66. Aerosol formulation containing particulate formoterol, propellant and polar cosolvent
     
67. Storage stable powder compositions of interleukin-4 receptor
     
68. Aerosol composition comprising formoterol
     
69. Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
     
70. High storage stability inhalable compositions
     
71. High efficient delivery of a large therapeutic mass aerosol
     
72. Delivery of analgesics through an inhalation route
     
73. Systemic administration of a therapeutic preparation
     
74. Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
     
75. Pulmonary administration of chemically modified insulin
     
76. Liquid droplet aerosols of nanoparticulate drugs
     
77. Delivery of diazepam through an inhalation route
     
78. Delivery of erectile dysfunction drugs through an inhalation route
     
79. Compositions and methods for the pulmonary delivery of aerosolized macromolecules
     
80. Delivery of muscle relaxants through an inhalation route
     
81. Delivery of antidepressants through an inhalation route
     
82. Delivery of stimulants through an inhalation route
     
83. Delivery of opioids through an inhalation route
     
84. Formulation for spray-drying large porous particles
     
85. Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
     
86. Porous particles comprising excipients for deep lung delivery
     
87. Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
     
88. Methods and compositions for the pulmonary delivery insulin
     
89. Delivery on nonsteroidal antiinflammatory drugs through an inhalation route
     
90. Pharmaceutical aerosol composition containing HFA 227 and HFA 134a
     
91. Methods and compositions for pulmonary delivery of insulin
     
92. Compositions and methods for the pulmonary delivery of aerosolized medicaments
     
93. Preparation of novel particles for inhalation
     
94. Aerodynamically light particles for pulmonary drug delivery
     
95. Pulmonary delivery in treating disorders of the central nervous system
     
96. Modulated release particles for aerosol delivery
     
97. Method for preparing a viral aerosol
     
98. Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
     
99. Aerosols containing annealed particulate salbutamol and tetrafluoroethane
     
100. Medicinal aerosol formulation
      
101. Microemulsion aerosol composition
      
102. Aerosol formulations of peptides and proteins
      
103. Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
      
104. Aerodynamically light particles for pulmonary drug delivery
      
105. Stable pharmaceutical budesonide preparation for producing propellant-free aerosols
      
106. Powders comprising anti-adherant materials for use in dry powder inhalers
      
107. Process for the preparation of suspensions of drug particles for inhalation delivery
      
108. Aerodynamically light particles for pulmonary drug delivery
      
109. Stabilization of lipid:DNA formulations during nebulization
      
110. Composition for treating cancer via liposomal aerosol formulation containing taxol
      
111. Method for preparing a viral aerosol and its use in gene therapy treatment
      
112. Liposomal aerosols for delivery of chemotherapeutic retinoids to the lungs
      
113. Pressurized device comprising an ultrafine foaming oil-in-water emulsion and use of this emulsion in cleansing and care of skin
      
114. Pressurized container having an aerosolized pharmaceutical composition
      
115. Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy
      
116. Aerosol pharmaceutical formulation for pulmonary and nasal delivery
      
117. Nebulized aerosols containing nanoparticle dispersions
      
118. Internal liquid composition contained as internal liquid in a releasing container and releasing container product
      
119. Porous particles for deep lung delivery
      
120. Propellant mixtures and aerosols for micronizing medicaments with compressed gas
      
121. Solid particulate propellant systems and aerosol containers employing the same
      
122. Aerosol ointment compositions for topical use
      
123. Pulmonary delivery of protonated/acidified nucleic acids
      
124. Formulations for pulmonary delivery of dopamine agonists
      
125. Pulmonary administration of soluble complement receptor-1 (sCR1) and its derivatives
      
126. Fluorocarbon compositions for pulmonary therapy
      
127. Carrier particles for use in dry powder inhalers
      
128. Aerodynamically light particles for pulmonary drug delivery
      
129. Aerosol package compositions containing fluorinated hydrocarbon propellants
      
130. Aerosol preparation
      
131. Aerosol formulations containing a sugar as a dispersant
      
132. Pressurized aerosol inhalation compositions
      
133. Buccal polar spray or capsule
      
134. Stabilization of lipid:DNA formulations during nebulization
      
135. Small particle liposome aerosols for delivery of anti-cancer drugs
      
136. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
      
137. Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
      
138. Medicinal inhalation aerosol formulations containing budesonide
      
139. Seal configuration for aerosol canister
      
140. Container for aerosol formulation
      
141. Device for delivering an aerosol
      
142. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
      
143. Methods and compositions for pulmonary delivery of insulin
      
144. Compositions and methods for nucleic acid delivery to the lung
      
145. Flunisolide aerosol formulations
      
146. Concentrated aerosol space spray that is not an emulsion

Drug Delivery System, Antacid/Anti-Gas

1. Method of making coated chewing gum products containing various antacids
    
2. Coated chewing gum products containing an antigas agent
    
3. Coated chewing gum products containing antacid and method of making
    
4. Coated chewing gum products containing an acid blocker and process of preparing
    
5. Pharmaceutical antacid
    
6. Antiflatulent composition
    
7. Translucent antacid suspension containing co-dried dihydroxy aluminum sodium carbonate
    
8. Simethicone/anhydrous calcium phosphate compositions
    
9. Pharmaceutical, orally applicable composition
    
10. Simethicone containing pharmaceutical compositions
     
11. Liquid antacid compositions